Health Winners & Losers: Wyeth
October 11th, 2008 | by admin |Health stocks followed the broader market rollercoaster Friday — a light news day for the sector despite the volatility.
- Related Articles
- Health Winners & Losers: King Pharma
- Health Winners & Losers: Genentech
- Health Winners & Losers: Pfizer
- Market Activity
- Biogen IDEC Incorporated| BIIB
- Genentech Inc| DNA
- Gilead Sciences Incorporated| GILD
The Nasdaq and Amex biotechnology indices ended down 3.2% and 3.56%, after rebounding from losses as great as 8% earlier in the day.
The Amex pharmaceutical index settled>(WYE Quote - Cramer>(TEVA Quote - Cramer>(ITMN Quote - Cramer>(BIIB Quote - Cramer>(MRX Quote - Cramer>(DNA Quote - Cramer>(GILD Quote - Cramer on GILD - Stock Picks) on Thursday. Genentech shares closed down $5.75, or 7.3%, to $73, and Gilead closed lost $2.57, or 6.4%, to $37.47.
